2seventy bio Inc (NASDAQ:TSVT) price closed on Monday, March 17, and remained unchanged from its previous close.
A look at the daily price movement shows that the last close reads $4.95, with intraday deals fluctuated between $4.94 and $4.965. The company’s 5Y monthly beta was ticking 1.736. Taking into account the 52-week price action we note that the stock hit a 52-week high of $5.99 and 52-week low of $2.29. The stock added 94.12% on its value in the past month.
2seventy bio Inc, which has a market valuation of $255.36 million, is expected to release its quarterly earnings report on 2024-Nov-11.
On average, analysts have forecast the company’s revenue for the quarter will hit 13.03M, with the likely lows of 10.27M and highs of 17.5M. The average estimate suggests sales growth for the quarter will likely rise by 22.00% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 49.89M for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow -50.30% below that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TSVT a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 7 analysts have assigned TSVT a recommendation rating as follows: 1 rate it as a Hold; 5 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the 2seventy bio Inc (TSVT) stock as Underweight, with 1 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that TSVT’s price is at present 54.28% off the SMA20 and 75.42% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 81.87, with weekly volatility standing at 0.43%. The indicator jumps to 6.65% when calculated based on the past 30 days. 2seventy bio Inc (NASDAQ:TSVT)’s beta value is holding at 1.10, while the average true range (ATR) indicator is currently reading 0.27. Considering analysts have assigned the stock a price target range of $2-$2 as the low and high respectively, we find the trailing 12-month average consensus price target to be $2. Based on this estimate, we see that current price is roughly 59.6% off the estimated low and 59.6% off the forecast high. Investors will no doubt be excited to see the share price rise to $2, which is the median consensus price, and at that level TSVT would be 59.6% from current price.
An analysis of the 2seventy bio Inc (NASDAQ:TSVT) stock in terms of its daily trading volume indicates that the 3-month average is 997.34K. However, this figure increases on the past 10-day timeline to an average of 4.43 million.
Current records show that the company has 51.51M in outstanding shares. The insiders’ percentage holdings are 8.63% of outstanding shares while the percentage share held by institutions stands at 86.92%. The stats also highlight that short interest as of 2025-02-28, stood at 4.8 million shares, which puts the short ratio at the time at 17.13. From this we can glean that short interest is 1126.00 of company’s current outstanding shares. Notably, we see that shares short in February fall slightly given the previous month’s figure stood at 5.18 million. But the 68.37% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
